NDC 24338-019 – Arynta

Lisdexamfetamine Dimesylate 10 mg/mL · Solution · Oral

Human Prescription Drug DEA schedule CII

Product NDC24338-019

Product details

Brand name
Arynta
Generic name
Lisdexamfetamine dimesylate oral
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
Solution
Route
Oral
Marketing category
NDA · NDA219847
Marketed since
March 20, 2026
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Arynta →

Package NDC codes (1)

Package NDCDescriptionSince
24338-019-011 BOTTLE in 1 CARTON (24338-019-01) / 100 mL in 1 BOTTLEMar 20, 2026

Other Arynta products